Eylea Label For Retinopathy Of Prematurity Should Specify ‘Treatment Tradeoff’ Versus Laser
Executive Summary
US FDA advisory committee recommends ‘more granularity’ in label on administration of Eylea in premature infants. Specifying intervals between injections is important for insurance coverage, agency official notes.